Bid guide
How to bid on an Illumina NextSeq 2000 Sequencing System for Defense Health Agency
What the agency is buying
The Defense Health Agency Contracting Activity (DHACA) intends to acquire one Illumina NextSeq 2000 Sequencing System. This system is needed to replace an existing Illumina NextSeq 550 system that is nearing its end-of-life.
The new system will support the Armed Forces Medical Examiner System (AFMES) and the Defense POW/MIA Accounting Agency (DPAA) in identifying missing service members. The agency states that this specific system is required to maintain mission continuity and handle an increased sample workload, while being compatible with existing validated assays.
Key dates and deadlines
This is a Presolicitation notice, published on August 03, 2026. Interested parties must submit their capability statements by August 18, 2026, at 12:00 PM Eastern Standard Time (EST).
The government will consider all capability statements received by this deadline. A decision on whether to proceed with a competitive procurement will be made based on these responses.
Who this opportunity suits
This opportunity is primarily for vendors who can supply an Illumina NextSeq 2000 Sequencing System. The agency has indicated that Illumina, Inc. is the only responsible source, but they are open to receiving information from other interested parties.
The procurement is classified under North American Industry Classification System (NAICS) 334516, which has a small business size standard of 1,000 employees. There are no set-aside restrictions for this requirement.
How to respond
To respond to this notice, you must submit technical data, including cost information, that demonstrates your capability to provide the Illumina NextSeq 2000 Sequencing System or an equivalent.
Capability statements should be sent via email to Jeffrey Sprecher at [email protected]. Acceptable formats for attachments include PDF, MS Word, and Excel. Phone calls will not be accepted.
Tips for preparing a competitive response
Carefully review the required minimum essential characteristics listed in the notice. Your submission should clearly demonstrate how your proposed system meets or exceeds each of these specifications, especially regarding compatibility with existing assays and throughput.
Even though the agency has identified a sole source, a well-prepared capability statement can still be valuable. Focus on providing detailed technical information and cost data that directly addresses the agency's needs and explains how your solution offers similar benefits without the stated re-development costs or mission delays. Ensure your submission is concise, professional, and submitted before the deadline.
See the live bid — deadline, agency details, and how to respond
Dates and requirements can change via addenda; always verify on the bid page and at the original source before responding.
View this bid on BiddingSimpleThis guide was prepared by BiddingSimple from the solicitation’s public posting. It is not official guidance from Defense Health Agency Contracting Activity; the original posting controls.